Rexahn Pharmaceuticals (NYSEMKT:RNN)

CAPS Rating: 1 out of 5

Caps

How do you think RNN will perform against the market?

Add Stock to CAPS Watchlist

All Players

85 Outperform
22 Underperform
 

All-Star Players

5 Outperform
14 Underperform
 

Wall Street

1 Outperform
0 Underperform
 

Top RNN Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Louiethelooper (< 20)
Submitted April 20, 2010

Investors misunderstood Dr. Ahn's NYC announcement about Serdaxin results. The man used to work for the FDA and has been in scientific research all his life. He's no fool. He didn't travel all the way to NYC to try to hoodwink Wall Street. Serdaxin… More

zzlangerhans (99.82)
Submitted January 15, 2014

Howdy Muggles! How's 2014 treating you so far? I've barely had time to look at the S&P this year as I'm focused on keeping my seat on the flying broomstick of biopharma. Grinding out 10% annual gains is an awesome accomplishment in the world of… More

RNN VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from players about RNN.

Recs

0
Member Avatar SmartAce (99.94) Submitted: 8/23/2017 2:38:15 PM : Underperform Start Price: $1.84 RNN Score: -26.75

I like telling car salesmen "Listen, we both know I'm not here to buy a car" and trying to figure out what it is they think I'm there to do.

Recs

0
Member Avatar DigitalDisco (84.24) Submitted: 5/5/2017 2:11:55 PM : Underperform Start Price: $3.76 RNN Score: +41.11

reverse split

Recs

0
Member Avatar solutionorppt (34.00) Submitted: 4/28/2015 12:45:12 PM : Outperform Start Price: $7.22 RNN Score: -85.03

Phase I results for Supinoxin and RX-3117 should be released later in H1 2015 and Phase 2b for Archexin in H2 2015.

The release of positive data from any of these studies will result in a significant uptick in the stock price. More importantly, a positive result from the Archexin study will generate strong partnership interest.

Leaderboard

Find the members with the highest scoring picks in RNN.

Score Leader

Rihanna

Rihanna (98.57) Score: +201.29

The Score Leader is the player with the highest score across all their picks in RNN.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
Rihanna 98.57 4/13/2010 Underperform 3M $33.90 -93.01% +108.28% +201.29 0 Comment
detroitigerz < 20 4/12/2010 Underperform 1Y $35.40 -93.30% +107.81% +201.11 0 Comment
Booey66 < 20 4/19/2010 Underperform 5Y $23.50 -89.91% +109.29% +199.21 0 Comment
Vanter1 99.34 4/15/2010 Underperform 3M $24.90 -90.48% +105.74% +196.22 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. icebit01 66.04 4/13/2010 Underperform 5Y $19.10 -87.59% +108.05% +195.64 0 Comment
stockjock11 < 20 4/14/2010 Underperform NS $19.70 -87.97% +106.84% +194.81 0 Comment
madmac99 < 20 10/18/2010 Underperform 1Y $11.80 -79.92% +111.55% +191.47 1 Comment
marlia79 57.73 4/14/2011 Underperform NS $12.00 -80.25% +90.57% +170.82 0 Comment
kaleidoscopic 70.04 11/18/2011 Underperform 3Y $5.49 -56.85% +103.74% +160.60 0 Comment
NYSEGOP 76.26 2/28/2012 Underperform 3M $5.11 -53.64% +81.27% +134.91 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackBreanMurray 77.86 12/2/2010 Outperform NS $11.70 -79.74% +105.51% -185.26 0 Comment

Featured Broker Partners